Dxn International Peru S.A.C.
Business Opportunity Assessment Report

Company Snapshot

DXN International Peru S.A.C. is a Peruvian legal entity operating as the local subsidiary of DXN Holdings Bhd — a Malaysia-based multinational specializing in Ganoderma-based health and wellness products. It functions primarily as a distributor and direct-selling network operator within Peru’s dietary supplement and natural health product market. Structurally, it relies almost exclusively on imports from Malaysia (84.2% of trade partners, 59.1% of sourcing countries), with Penang, Malaysia serving as its dominant export port (63.7% of shipments). A clear signal of operational continuity is observed: all top-tier trade relationships and HS codes remained active ('Maintained') through May 2026.

Company Attributes

Trade Trend Analysis

Data interpretation reveals extreme temporal concentration: over 60% of total transaction volume occurred in just five months — November 2024 (935K units), October 2024 (675K), September 2024 (634K), July 2024 (651K), and March 2025 (498K) — suggesting strong seasonal or campaign-driven demand cycles tied to Latin American wellness promotion calendars. The sustained high frequency (avg. 94 transactions/month) alongside volatile volume swings indicates a dynamic, membership-driven fulfillment model rather than static wholesale distribution. This pattern reflects a high-dependency, low-diversification operational rhythm anchored to periodic member enrollment surges and regional launch events.

Trade Partner Analysis

Data interpretation shows near-total vertical integration with its parent ecosystem: DXN Industries M Sdn Bhd (Malaysia) accounts for 84.2% of all transactions — confirming DXN Peru operates as a captive distribution arm, not an independent buyer. The second-largest partner (“No disponible”, Peru) represents only 15.05% of activity and lacks identifiable corporate identity, likely reflecting internal logistics or unregistered local fulfillment entities. All other partners are marginal (<0.31%), with no evidence of third-party supplier diversification. This structure confirms zero strategic autonomy in procurement — supply chain control resides entirely with the Malaysian headquarters.

HS Code Analysis

Data interpretation highlights extreme product focus: HS 2101120000 (instant coffee substitutes containing herbs or medicinal plants — specifically Ganoderma extracts) dominates at 44.9% of all transactions, followed by HS 2106909000 (other food preparations, n.e.s., including dietary supplements) at 20.5%. Together, these two codes represent >65% of import activity, reinforcing that DXN Peru’s core business is standardized, branded Ganoderma-based nutraceuticals — not general wellness merchandise. Minor codes (e.g., 3304990000 — other cosmetics, 1806900000 — chocolate/preparations) reflect complementary SKUs aligned with DXN’s ‘One World One Market’ cross-category bundling strategy. This coding profile confirms strict adherence to a vertically integrated, brand-controlled product portfolio — with no indication of private-label or white-label deviation.

Trade Region Analysis

Data interpretation shows overwhelming geographic dependency: Malaysia alone accounts for 59.1% of trade volume and hosts the sole dominant supplier (DXN Industries M Sdn Bhd), while Costa Rica — previously active (39.15% share) — has been inactive since November 2024, indicating a deliberate regional consolidation. China and Korea appear as minor but newly activated sources (0.7% and 0.31%, respectively), likely supporting localized packaging or co-manufacturing for Andean markets. The absence of U.S., EU, or regional LATAM suppliers confirms no localization or dual-sourcing strategy. This regional concentration signals high exposure to Malaysia-centric supply chain disruptions and limited regional resilience.

Export Port Analysis

Data interpretation demonstrates logistical centralization: Penang (Georgetown), Malaysia accounts for 63.7% of all shipments — aligning precisely with DXN’s manufacturing hub in Nibong Tebal, Penang. The secondary port “Mypen” (likely shorthand for Port of Penang) adds another 19.6%, bringing Malaysia-based port dominance to 83.3%. New ports — Santa Cruz (Bolivia), Tianjin Xingang (China), Pusan (South Korea), Santos (Brazil) — appear sporadically (≤1–2 transactions each), suggesting exploratory or pilot logistics routes for regional expansion, not established alternatives. This port structure confirms end-to-end control by DXN Malaysia’s logistics division — with no evidence of third-party warehousing or regional fulfillment centers.

Contact Information

• Official Website: https://www.dxn2ulatam.com/index.php?lang=en
• Peru Local Site: https://dxnla.com/
• Instagram: @dxnperuoficial
• LinkedIn (Corporate): DXN INTERNACIONAL
• Email: Not publicly disclosed (contact form only on dxn2ulatam.com)
• Phone: Not publicly disclosed (form-based inquiry only)
• Headquarters (Global): DXN Holdings Bhd, Lot 1234, Jalan Perusahaan, Bayan Lepas Free Industrial Zone, 11900 Penang, Malaysia

Company Trade Summary

• DXN Peru is a fully controlled distribution subsidiary — not an autonomous importer or retailer.
• Over 99% of procurement flows exclusively from Malaysia, centered on two HS codes covering Ganoderma-based dietary supplements and functional foods.
• All logistics originate from Penang, Malaysia — confirming zero regional inventory or fulfillment decentralization.
• Recent activation of ports in China, Korea, Brazil, and Bolivia signals early-stage LATAM+ expansion testing — but remains statistically negligible (<2% combined).
• No evidence of third-party supplier engagement, private labeling, or product diversification beyond the DXN global portfolio.